Sign In
Section Navigation
Common TitleACTG 364
Official Title Comparison of the Virologic Efficacy of Nelfinavir and/or Efavirenz, EFV (DMP 266) in Combination With One or Two New Nucleoside Analogs in Nucleoside Experienced Subjects: A Roll-Over Study to ACTG 302/303
Phase Phase II
ClinicalTrials.gov NCT00001087
Treatments
Nelfinavir
Nelfinavir Viracept

Nelfinavir

Tradename:ViraceptOther Names:NFVClass:Protease Inhibitors (PI)
Categories Treatment-ExperiencedResistance/Virological Failure
Funding
Non-IndustryNational Institute of Allergy and Infectious Diseases (NIAID)
References
  • Albrecht MA, Bosch RJ, Hammer SM, et al. Nelfinavir, efavirenz, or both after the failure of nucleoside treatment of HIV infection. N Engl J Med. 2001;345:398-407.
    [PubMed Abstract]
  • Katzenstein DA, Bosch RJ, Hellmann N, Wang N, Bacheler L, Albrecht MA. Phenotypic susceptibility and virological outcome in nucleoside-experienced patients receiving three or four antiretroviral drugs. AIDS. 2003;17:821-30.
    [PubMed Abstract]

Share by e-mail

Since you've received 80% or better on this quiz, you may claim continuing education credit.

You seem to have a popup blocker enabled. If you want to skip this dialog please Always allow popup windows for the online course.